Jupiter Neurosciences, Inc. (JUNS)
2.20
+0.07
(+3.29%)
USD |
NASDAQ |
Nov 06, 16:00
2.01
-0.19
(-8.64%)
After-Hours: 20:00
Jupiter Neurosciences Net Income (Quarterly) : -2.274M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.274M |
| March 31, 2026 | -2.062M |
| December 31, 2025 | -2.575M |
| September 30, 2025 | -2.288M |
| June 30, 2025 | -2.253M |
| March 31, 2025 | -1.529M |
| December 31, 2024 | -1.528M |
| September 30, 2024 | -0.591M |
| June 30, 2024 | 0.3131M |
| March 31, 2024 | -0.6341M |
| December 31, 2023 | -0.4296M |
| Date | Value |
|---|---|
| September 30, 2023 | -1.774M |
| June 30, 2023 | -0.8326M |
| March 31, 2023 | -1.747M |
| December 31, 2022 | -1.748M |
| September 30, 2022 | -1.559M |
| June 30, 2022 | -0.8565M |
| March 31, 2022 | -0.7945M |
| December 31, 2021 | -1.906M |
| September 30, 2021 | -1.190M |
| March 31, 2021 | -0.2308M |
| September 30, 2020 | -0.488M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Johnson & Johnson | 210.00M |
| ANI Pharmaceuticals, Inc. | 32.72M |
| Corcept Therapeutics, Inc. | 124.49M |
| Veru, Inc. | -6.988M |
| Eli Lilly & Co. | 6.451B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.0242M |
| Total Expenses (Quarterly) | 2.299M |
| EPS Diluted (Quarterly) | -4.079 |
| Enterprise Value | 1.716M |
| Gross Profit Margin (Quarterly) | 87.19% |
| Profit Margin (Quarterly) | -9.40K% |
| Earnings Yield | -868.8% |
| Normalized Earnings Yield | -919.74 |